ELMS STEVE

CIK 000125019521 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001250195

Recent Transactions

50 trades

Award
Marker Therapeutics, Inc.$MRKR
Stock Option (right to buy)
2025-11-17+84,411→ 84,411 total
Award
Marker Therapeutics, Inc.$MRKR
Stock Option (right to buy)
2025-11-17+137,330→ 137,330 total
Disposition to Issuer
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-07-23−31,238→ 0 total
Disposition to Issuer
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-07-23−35,000→ 0 total
Disposition to Issuer
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-07-23−35,000→ 0 total
Disposition to Issuer
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-07-23−15,619→ 0 total
Disposition to Issuer
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-07-23−31,238→ 0 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-16$20.24/sh−194,749→ 87,330 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−53,837→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$2.92/sh+15,000→ 222,667 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$5.96/sh+9,000→ 96,330 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$3.66/sh+53,837→ 160,167 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$3.89/sh+30,000→ 207,667 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−10,000→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$5.40/sh+37,541→ 420,010 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−37,541→ 0 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$20.82/sh−137,931→ 282,079 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−9,000→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−15,000→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−53,172→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$2.35/sh+55,000→ 277,667 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$4.91/sh+17,500→ 177,667 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−17,500→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$5.00/sh+10,000→ 106,330 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$3.35/sh+51,630→ 382,469 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−55,000→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-13$1.67/sh+53,172→ 330,839 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−51,630→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-06-13−30,000→ 0 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-06-12$21.69/sh−92,941→ 2,031,730 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2025-06-05+35,000→ 35,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2025-02-19+10,889→ 87,330 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2025-02-19+16,279→ 16,279 total
Award
Marker Therapeutics, Inc.$MRKR
Stock Option (right to buy)
2025-02-12+30,000→ 30,000 total
Purchase
Marker Therapeutics, Inc.$MRKR
Common Stock
2024-12-23$3.20/sh+11,085→ 325,370 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-11-27$10.80/sh+9,000→ 2,124,671 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Stock Option (Right to Buy)
2024-11-27−9,000→ 0 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2024-06-13+35,000→ 35,000 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-03-19$6.08/sh−411,829→ 2,115,671 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-03-18$6.01/sh−49,887→ 2,527,500 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-03-15$6.01/sh−183,008→ 2,577,387 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-03-14$6.05/sh−448,276→ 2,760,395 total
Sale
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-03-13$6.21/sh−407,000→ 3,208,671 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2024-02-26+24,040→ 76,441 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2024-02-26+37,541→ 37,541 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total
Award
Marker Therapeutics, Inc.$MRKR
Stock Option (right to buy)
2023-06-06+8,000→ 8,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2023-03-06+25,815→ 52,401 total
Award
ADMA BIOLOGICS, INC.$ADMA
Employee Stock Option (right to buy)
2023-03-06+51,630→ 51,630 total
Award
Elevation Oncology, Inc.
Stock Option (Right to Buy)
2022-06-17+15,619→ 15,619 total

Recent Filings

Address

C/O PERSEUS SOROS MANAGEMENT, LLC 888 7TH AVENUE - 30TH FLOOR

NEW YORK, NY, 11375

View on SEC.gov